Aeolus Pharmaceuticals Inc. recently started a Phase 1 test of AEOL 10150 on healthy people as part of its efforts to determine whether it can delay the effects of acute radiation exposure in the lungs.
Researchers at the Vanderbilt University are making significant progress in decoding the molecular genetics of ant communication that takes place through a waxy layer of odors that coats their bodies.
Bristol-Myers Squibb and Pfizer said Eliquis (apixaban) showed a significantly lower risk of stroke or systemic embolism and lower rate of major bleeding compared to warfarin in an analysis of Medicare data involving patients with non-valvular atrial fibrillation.
A Phase 3 CHRONOS test from Sanofi and Regeneron Pharmaceuticals of the drug Dupixent shows promise in patients with uncontrolled moderate to severe atopic dermatitis when used with a topical corticosteroid.
Once skin cancer in advanced stages has been surgically removed, Opdivo may be the best option to keep the malignancy at bay, according to a Phase 3 clinical trial sponsored by manufacturer Bristol-Myers-Squibb.
Texas Medical Center (TMC) recently reported on the efforts of McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) microbiologists to develop a new treatment for patients suffering from a fungal yeast infection in the mouth known as thrush.